Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Fostering F.A.I.R. Data and Standards in Rare Hematological Diseases

Project description

Improving research and diagnosis in rare blood diseases

Millions of people in Europe suffer from rare diseases. However, research remains scarce and fragmented, leading to delayed diagnoses and limited treatment options. A key barrier is the lack of standardised, interoperable data. To address this challenge, the EU-funded HemaFAIR project aims to promote FAIR principles, ensuring research data is findable, accessible, interoperable, and reusable. The project focuses on rare haematological diseases and is built around a network of European experts. The key objective is to develop training programmes, mentoring initiatives, and collaborative research projects. HemaFAIR is anticipated to strengthen research capacity in Cyprus and foster cross-border collaboration, accelerating scientific discovery and improving care for patients with rare blood diseases.

Objective

Research on rare diseases (RDs) is scarce and fragmented in the EU, leading to delayed diagnoses, limited availability of medicinal products and challenging access to care. Like in most RDs, data-driven research on rare haematological diseases (RHDs) is affected by the lack of data standardisation and the fragmentation of available data in close repositories. Adhering to the principle of making data findable, accessible, interoperable and reusable (FAIR) is pivotal in fostering collaborative research and maximising the potential of available data. FAIR principles are especially relevant in the context of RD research, as their use can help to tackle data fragmentation and accelerate scientific discoveries.
HemaFAIR aims to unravel the scientific excellence and innovation potential of a Widening country (Cyprus), through an EU network of excellence on the use of FAIR principles in RHD research. As a reference centre for most RDs in Cyprus, the Cyprus Institute of Neurology & Genetics (CING) can serve as a model for raising the scientific profile and competitiveness of Cyprus in RDs/RHDs and biomedical informatics and strengthening the research management and administrative skills. HemaFAIR brings together key experts in RHD research, biomedical informatics, patient-centred research and ethics and regulatory issues.
HemaFAIR will develop and implement a comprehensive training programme and numerous capacity-building and strategic networking activities, including summer schools, workshops, webinars, and transferrable skills lectures. Also, HemaFAIR will raise the profile of early-career researchers via the development of a mentoring programme, short-term staff exchanges and three collaborative research projects. Notably, the research component of HemaFAIR will demonstrate the FAIRification process on two existing platforms for haemoglobinopathies, a group of RHDs that are particularly prevalent in Cyprus, thus maximising the impact of the project on the local society.

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-CSA - HORIZON Coordination and Support Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-WIDERA-2023-ACCESS-02

See all projects funded under this call

Coordinator

KYPRIAKO IDRYMA EREVNON GIA TI MYIKI DISTROFIA
Net EU contribution
€ 625 625,00
Address
6 IROON AVENUE
2371 AGIOS DOMETIOS
Cyprus
Region
Κύπρος Κύπρος Κύπρος
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Participants (4)